Your session is about to expire
← Back to Search
Device
Remote Heart Failure Management for Heart Failure
N/A
Recruiting
Led By Michael W Fong, MD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 14 days after enrollment and approximately 90-days post-enrollment
Awards & highlights
Study Summary
This trial is testing whether using a digital platform to manage heart failure patients leads to better health outcomes than usual care.
Who is the study for?
This study is for English-speaking adults over 18 who've been discharged from the hospital with heart failure within the last two weeks. Participants need a working phone, internet access, and a secure place for the Bodyport device. They must be able to stand on a scale but weigh less than 375 lbs. Those with severe kidney disease, certain implants, or noncompliance history are excluded.Check my eligibility
What is being tested?
The trial is examining how well the Bodyport Cardiac Scale works in managing heart failure remotely compared to usual care at Keck Medical Center of USC. It's checking if this virtual clinic can help patients manage their condition better at home.See study design
What are the potential side effects?
Since this trial involves remote monitoring rather than medication or invasive procedures, traditional side effects aren't expected. However, there may be privacy concerns regarding data handling and potential stress related to technology use.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 14 days after enrollment and approximately 90-days post-enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 14 days after enrollment and approximately 90-days post-enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in quality of life
Scale Adherence
Secondary outcome measures
Patient and provider satisfaction
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: BodyPort Cardiac ScaleExperimental Treatment1 Intervention
Patient will receive the Bodyport scale with access to Bodyport care services, such as remote monitoring, educational materials, different biomarkers detected by the scale, and online access to their data
Group II: ControlActive Control1 Intervention
Patients will receive usual care and a Bodyport scale that only displays weight and weight change. No other access to care services, features, or materials will be provided during this 90 day period
Find a Location
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
905 Previous Clinical Trials
1,596,256 Total Patients Enrolled
5 Trials studying Heart Failure
603 Patients Enrolled for Heart Failure
Michael W Fong, MDPrincipal InvestigatorKeck Medical Center of USC
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a history of not following your doctor's treatment instructions.You weigh more than 375 pounds.You can't stand on the Bodyport scale for the time it takes to collect data.You are currently in jail or do not have a stable place to live.You have a CardioMEMs pulmonary artery sensor in your body.You have been diagnosed with heart failure and were discharged from the hospital for a heart failure episode within the last 14 days.You have had a heart transplant in the past.You have severe chronic kidney disease or are receiving hemodialysis.You have a special device to help your heart pump blood.You can stand safely on the Bodyport scale.
Research Study Groups:
This trial has the following groups:- Group 1: BodyPort Cardiac Scale
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still vacancies available for this investigation?
"Affirmative. Clinicaltrials.gov records show that this study is currently recruiting participants, having initially been posted on May 10th 2021 and last updated on 23rd of the same month in 2022. 22 individuals are required across one site for full enrolment."
Answered by AI
How many participants are currently undergoing the therapeutic trial?
"Yes, according to clinicaltrials.gov this research is still recruiting patients. Initially posted on May 10th 2021 and most recently modified on the 23rd of May 2022, 22 individuals are required to participate at a single investigational site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger